SCHEMBL17023089

SCHEMBL17023089

CCN1CCN(c2ccc(NC(=O)Oc3ccc(-c4cc(OC)ccc4Cl)c4nccnc34)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 6/20 0.48
LMNA P02545 2/20 0.47
MAPT P10636 5/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
POLB P06746 1/20 0.45
CHRM1 P11229 1/20 0.45
TSHR P16473 3/20 0.43
REV1 Q9UBZ9 1/20 0.42
GFER P55789 1/20 0.42
USP2 O75604 1/20 0.42
PABPC1 P11940 1/20 0.42
APOBEC3A P31941 1/20 0.42
EIF4H Q15056 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
JAK2 O60674 1/20 0.41
ABL1 P00519 1/20 0.41
INSR P06213 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17023074 0.91 FGFR3 (0.59) FGFR3LMNAMAPTCHRM1TSHR
SCHEMBL1126965 0.88 FGFR3 (0.60) FGFR3LMNAMAPTSMN1; SMN2NPC1
SCHEMBL17023062 0.85 FGFR3 (0.66) FGFR3LMNAMAPTSMN1; SMN2NPC1
SCHEMBL17023029 0.79 FGFR3 (0.50) FGFR3LMNAMAPTSMN1; SMN2NPC1
SCHEMBL1126083 0.79 FGFR3 (0.74) FGFR3MAPTCHRM1TSHR
SCHEMBL17023106 0.79 HRH3 (0.47) FGFR3SMN1; SMN2ABL1LCKBCR
SCHEMBL17023181 0.78 FGFR3 (0.59) FGFR3LMNAPOLBJAK2ABL1
SCHEMBL17023180 0.77 NPC1 (0.49) FGFR3LMNAMAPTSMN1; SMN2NPC1
SCHEMBL17023176 0.76 FGFR3 (0.80) FGFR3JAK2ABL1INSRLCK
SCHEMBL17023067 0.76 FGFR3 (0.65) FGFR3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed